Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
US8163927B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2007 |
| Grant date | Apr 24, 2012 |
| Priority date | — |
| Expiry date | Aug 1, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to certain azabicyclic compounds of formula (I)′:wherein the several groups are defined herein and are modulators of dopamine D3 receptors, e.g. to treat drug dependency, as antipsychotic agents, to treat obsessive compulsive spectrum disorders, or premature ejaculation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.